| Authors: |
Proto WR; Malaria Programme, Wellcome Sanger Institute,Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Siegel SV; Malaria Programme, Wellcome Sanger Institute,Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Dankwa S; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Liu W; Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, 19104, USA., Kemp A; Malaria Programme, Wellcome Sanger Institute,Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Marsden S; Malaria Programme, Wellcome Sanger Institute,Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Zenonos ZA; Malaria Programme, Wellcome Sanger Institute,Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Unwin S; Chester Zoo, Chester, CH2 1LH, UK.; School of Biosciences, University of Birmingham, Edgbaston, B15 2TT, UK., Sharp PM; Institute of Evolutionary Biology, University of Edinburgh, Edinburgh, UK., Wright GJ; Malaria Programme, Wellcome Sanger Institute,Wellcome Genome Campus, Cambridge, CB10 1SA, UK., Hahn BH; Departments of Medicine and Microbiology, University of Pennsylvania, Philadelphia, PA, 19104, USA.; Department of Microbiology, University of Pennsylvania, Philadelphia, PA, 19104, USA., Duraisingh MT; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Rayner JC; Malaria Programme, Wellcome Sanger Institute,Wellcome Genome Campus, Cambridge, CB10 1SA, UK. julian.rayner@sanger.ac.uk.; Cambridge Institute for Medical Research, University of Cambridge, Hills Road, Cambridge, CB2 0XY, UK. julian.rayner@sanger.ac.uk. |
